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Editor: Damia BarceloThere is concern that psychoactive drugs present in the aquatic environment could affect the behaviour of fish,
and other organisms, adversely. There is considerable experimental support for this concern, although the liter-
ature is not consistent. To investigate why, fish were exposed to three concentrations of the synthetic opiate
tramadol for 23–24 days, and their anxiolytic behaviour in a novel tank diving test was assessed both before
and after exposure. The results were difficult to interpret. The positive control drug, the anti-depressant fluoxe-
tine, produced the expected results: exposed fish explored the novel tank more, and swam more slowly while
doing so. An initial statistical analysis of the results provided relatively weak support for the conclusion that
both the low and high concentrations of tramadol affected fish behaviour, but no evidence that the intermediate
concentration did. To gain further insight, UK and Japanese experts in ecotoxicology were asked for their inde-
pendent opinions on the data for tramadol. These were highly valuable. For example, about half the experts
replied that a low concentration of a chemical can cause effects that higher concentrations do not, although a sim-
ilar number did not believe thiswas possible. Based both on the inconclusive effects of tramadol on the behaviour
of the fish and the very varied opinions of experts on the correct interpretation of those inconclusive data, it is
obvious that more research on the behavioural effects of tramadol, and probably all other psychoactive drugs,





Varied opinions of expertsental Studies, Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime 790-8577, Japan.
rumi.lw@ehime-u.ac.jp (R. Tanoue).
. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
916 R. Tanoue et al. / Science of the Total Environment 664 (2019) 915–926these findingsmay apply muchmore widely than just the environmental risk assessment of psychoactive drugs.
They suggest that much more rigorous training of research scientists and regulators is probably required if
consensus decisions are to be reached that adequately protect the environment from chemicals.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Many human pharmaceuticals and their metabolites are present in
the aquatic environment, usually at concentrations in the low or even
sub-ng/L range (Petrović et al., 2014; Batt et al., 2016). The challenge
now is to identify which, if any, of these pharmaceuticals pose a threat
to aquatic organisms, and to what degree compared to the threat
posed by the many other chemicals present in probably every river of
most countries (Malaj et al., 2014; Johnson et al., 2017).
Amongst the drugs that have been detected in the aquatic environ-
ment are many psychoactive drugs, both legal (Schlüsener et al., 2015;
Fick et al., 2017) and illegal (Kasprzyk-Hordern et al., 2008). This is
not surprising, given that there are many (a few hundred) different
psychoactive drugs on the market and that some of them are amongst
themostwidely prescribed of all drugs. The legal psychoactive drugs in-
clude those given to induce anaesthesia (e.g., ketamine), manage pain
(e.g., opioids), and treat a wide variety of mental disorders (e.g., anti-
depressants). The range of psychoactive recreational drugs is equally
large, including as it does stimulants (e.g., cocaine, methamphetamine)
and hallucinogens (e.g., D-lysergic acid diethylamide). By far the most
comprehensive assessment to date of the presence of psychoactive
drugs in the aquatic environment has been provided by Kasprzyk-
Hordern and her colleagues. They have shown that a large number of
legal and illegal psychoactive drugs are present in a typical river of a de-
veloped country (Baker and Kasprzyk-Hordern, 2013; Petrie et al.,
2016). Activemetabolites of some of these parent drugs are also present
(Petrie et al., 2016).
Most psychoactive drugs are hydrophobic because to have their de-
sired effects they need to cross the blood-brain barrier to act in the
brain. Unfortunately their hydrophobicity means that once in the
aquatic environment theywill be readily taken upby aquatic organisms.
Wild fish from the United States (Brooks et al., 2005; Arnnok et al.,
2017), Europe (Huerta et al., 2013; Álvarez-Muñoz et al., 2015) and
Japan (Tanuoe et al., 2015) have been shown to contain various psycho-
active drugs, with most research demonstrating the presence of the
anti-depressants fluoxetine and sertraline and the anti-epileptic carba-
mazepine. The highest concentrations of psychoactive drugs in wild
fish are often reported to be in the brain (e.g., Arnnok et al., 2017),
which is the main site of action for most of these drugs.
Understandably, biologists have become interested in determining
whether or not psychoactive drugs alter behaviours of aquatic organ-
isms. The targets of psychoactive drugs are highly conserved through-
out the animal kingdom (Gunnarsson et al., 2008), and hence based
on the read-across hypothesis (Rand-Weaver et al., 2013), similar ef-
fects of psychoactive drugs might be expected to occur in both humans
and aquatic organisms (especially vertebrates such as fish) if plasma
concentrations in these organisms reach those that cause therapeutic
effects in humans. Ecotoxicologists have studied the effects – if any, of
course – of a few psychoactive drugs on a wide range of species includ-
ing both aquatic vertebrates (i.e., fish) and invertebrates (i.e., molluscs
and shrimps). The majority of this research has focused on possible ef-
fects of anti-depressants, as reviewed in Sumpter et al. (2014), although
there is also a growing body of research on the possible effects of the
anti-anxiety drug oxazepam on the behaviour of fish (e.g., Brodin
et al., 2017; Lagesson et al., 2018). Because studying the behaviour of
wildfish in their natural environmentwould be extraordinarily difficult,
in most cases the research has involved exposing fish to the drugs in
laboratories, then investigating the behaviour of those fish. A varietyof different behaviours, including feeding rate (e.g., Stanley et al.,
2007), predator avoidance (e.g., Painter et al., 2009), capture of prey
(e.g., Bisesi Jr. et al., 2016), aggression (e.g., Kohlert et al., 2012),
shelter-seeking (e.g., Valenti Jr. et al., 2012), time spent in the upper
half of the aquarium (e.g., Margiotta-Casaluci et al., 2014) and boldness
(e.g., Brodin et al., 2017) have been chosen as endpoints. In almost all
cases it has been reported that the psychoactive drugs altered the be-
haviour of the fish in a manner that would likely have reduced their
fitness. Yet there are two major problems with this research. One is
that some papers contradict the results of other papers, making it
impossible to know which, if either, provide reproducible results. To
provide just one example, whereas Thompson et al. (2017) report that
the anti-depressant venlafaxine had pronounced adverse effects on
young fish, Parrott and Metcalfe (2017) observed no effects of that
drug over a full fish life cycle. The other is that different authors report
that very different concentrations, ranging from low ng/L to high μg/L,
are required in order to affect behaviour (Sumpter et al., 2014).
The current uncertainty over whether or not psychoactive drugs
affect the behaviour of fish, and if so, at what environmental concentra-
tions, and exactly how behaviour is affected, makes it impossible to de-
cidewhether or not these drugs constitute a significant threat to aquatic
wildlife. Regulators, whose job it is to protect the environment from the
many chemicals entering it, cannot reach a consensus position that
is defensible when confronted with such variability and uncertainty.
To highlight these current problems, we conducted an experiment in
whichfishwere exposed to a psychoactive drug, tramadol, and their be-
haviour assessed both before and after that exposure. In order to anchor
any behavioural effects of tramadol against the established behavioural
effects of another psychoactive drug, we chose to use fluoxetine as a
positive control. Then the results of that experiment were shown to a
large group of very experienced ecotoxicology researchers and regula-
tors, who were asked to provide their interpretations of the results.
2. Materials and methods
2.1. Selection of test chemicals
As our objective was to obtain a set of unique behavioural data for
experts to assess, rather than replicate an existing set, we wanted to
use a psychoactive drug that had not yet been studied for its effects on
aquatic organisms. We chose tramadol because it is in widespread use
across the world and because it appears to be present in the aquatic en-
vironment at higher concentrations than any other psychoactive drug.
Its concentration in rivers is usually reported to be in the hundreds of
ng/L range, and can be in the low μg/L range (Kasprzyk-Hordern et al.,
2008; Baker and Kasprzyk-Hordern, 2013; Petrie et al., 2016). The
toxic effects of tramadol on the early-life stage of zebrafish and common
carp were investigated by Sehonova et al. (2016). They tested different
concentrations ranging from 10 to 200 μg/L of tramadol hydrochloride.
They reported that the drug had effects on hatching, early ontogeny,
morphology, and histopathology. However, these effects appear uncon-
vincing, mainly because these were often not concentration-related.
Tramadol is a synthetic opiate used to treatmoderate to severe pain.
In people, it undergoes demethylation to the active metabolite O-
desmethyl tramadol, and this produces analgesia through μ-opioid
receptor-mediated inhibition of pain transmission in the spinal cord
(Minami et al., 2007; Myers, 2005; Vazzana et al., 2015). However,
tramadol has multiple mechanisms of action. It also elicits sedation by
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central nervous system (Faron-Górecka et al., 2004; Minami et al.,
2007; Myers, 2005; Vazzana et al., 2015), as antidepressant SSRIs do.
Common side effects in people include drowsiness, dizziness, anxiety,
and impaired thinking and motor skills. In rodent models, tramadol re-
duced anxiety and hence the animals explored their open environment
more in the elevated plus maze test, which is one of the most widely
used tests for assessing anxiety-like behaviour (Caspani et al., 2014;
Jayasree and Rajeswaramma, 2015). In a recent study (Buřič et al.,
2018), an aquatic invertebrate, the marbled crayfish, exhibited
significantly lower velocity and moved shorter distances than controls
following exposure to tramadol at water concentrations of 0.81–0.98
μg/L. The biological receptors which tramadol acts on are evolutionarily
conserved across vertebrate species (Albrizio et al., 2014; Gunnarsson
et al., 2008; Sanchez-Simon and Rodriguez, 2008). Given the “read-
across hypothesis” (Rand-Weaver et al., 2013), it is hypothesised that
tramadol elicits sedation and anxiolytic responses in fish, as shown in
the rodent models and humans, when the plasma tramadol concentra-
tion is within the human therapeutic concentration range. The anxio-
lytic response is ecologically relevant because it affects variables
important for survival and breeding. Thus, in the present study, anxio-
lytic behaviour in fish was assessed using the novel tank diving test.
The test is commonly used to measure anxiolytic responses of fish to
an unfamiliar environment (Cachet et al., 2010; Maximino et al.,
2012), which is conceptually similar to the elevated plus maze test
with rodents. Tramadol hydrochloride was purchased from Sigma-
Aldrich (Dorset, UK) with a purity higher than 99% (product number
42965-5G-F, lot number BCBN4547V).
In order to anchor any anxiolytic responses of tramadol against the
established anxiolytic behavioural effects of another psychoactive
drug, we used the antidepressant SSRI fluoxetine as a positive control.
Well-designed studies have been performed which indicate that
fluoxetine affects the anxiolytic behaviour of fish in a reproducible,
concentration-dependent manner, in the novel tank diving test
(e.g., Margiotta-Casaluci et al., 2014; Ansai et al., 2016). Fluoxetine
hydrochloride was purchased from Sigma-Aldrich (Dorset, UK) with a
purity higher than 99.9% (product number PHR1394, lot number
LRAA1901).
2.2. Experimental design
The basic experimental design was one we have used before to in-
vestigate the anxiolytic behavioural effects of two other psychoactive
drugs, fluoxetine (Margiotta-Casaluci et al., 2014) and oxazepam
(Huerta et al., 2016). The 23–24 days chronic exposure experiment
was carried out using a continuous flow-through system comprising
twelve 20.5 L glass tanks (dimensions: 45 cm (length) × 24 cm
(width) × 19 cm (depth)). Ten days before the beginning of the exper-
iment, sexually mature male fathead minnows (Pimephales promelas)
were transferred into the flow-through systems for acclimation to the
test conditions. The experiment was run with a photoperiod of 16 h
light: 8 h dark. During the experiment the water temperature, pH, and
dissolved oxygen concentration were 25 ± 1 °C, 7.8 ± 0.19 and
6.0–8.0 mg/L, respectively. Thermostatically-heated dechlorinated tap
water flowed into 12 glass mixing chambers at a rate of approximately
10 L/h, which supplied approximately 12 tank volumes per day to each
tank holding fish. The same mixing chambers also received concen-
trated stock solutions of the test drugs delivered via peristaltic pumps
at a flow rate of approximately 2mL/h. These stock solutions containing
test drugs were prepared every 4 days in amber bottles with N,N-
Dimethylformamide (DMF):Milli-Qwater (1:4, v/v) as a carrier solvent.
The final DMF concentration in the water of the fish tanks was approx-
imately 0.004%.
The experiment consisted of 6 different treatments: water control
(WC), solvent control (SC), 1 μg tramadol/L (TG-1), 10 μg tramadol/L
(TG-10), 100 μg tramadol/L (TG-100) and 100 μg fluoxetine/L (FG-100).There were two replicate tanks for each treatment. Eight male fathead
minnows (Pimephales promelas), approximately 7 months old, 2.6 ±
0.53 g weight, and 5.4 ± 0.30 cm length, were randomly allocated to
each fish tank, giving a total of 16 fish per treatment. The concentrations
of tramadol in the fish tanks were chosen to cover both environmentally
and pharmacologically-relevant concentrations, with the highest concen-
tration (100 μg/L) anticipated to produce fish plasma levels of tramadol
proximate to the human therapeutic plasma range of 100–300 ng/mL. A
schematic of the exposure aspect of the experiment is provided in
Fig. 1A. Full details of the analytical technique used to determine drug
concentrations in plasma and brain of fish as well as test water are pro-
vided in our previous paper (Tanoue et al., 2017).
The behaviour of all fish was assessed using the novel tank diving
test. The test is based on the instinctive behaviour of fish to seek protec-
tion in a novel environment by diving to the bottom of the tank and
staying there until the environmental conditions are perceived as safe
enough to initiate exploration. In order to obtain both pre-exposure
baseline behavioural data and post-exposure data, all fish were tested
twice; once immediately before exposure to a test chemical began
(i.e., on day 0) and again at the end of the exposure period. After testing
each fish individually at the beginning of the experiment, fish were
returned to the tank from which they came. That tank contained the
seven other fish maintained throughout in that tank. This meant that
it was not possible to link pre-exposure data with post-exposure data
for individual fish.
At the initiation of the novel tank diving test, each individual
fish was transferred from its exposure tank to a 8.2 L observation tank
(dimensions: 28 cm (length) × 13 cm (width) × 22.5 cm (depth)),
and the exploratory behaviour of the fish recorded for 18 min using a
Fujifilm digital camera (FinePix JV300; 14.0 Mpix) positioned at the
front of the tank. Nobody was in the room where the novel tank diving
tests were conducted while filming was occurring. The offline analysis
of fish exploratory behaviour was carried out using movement tracking
software as described by Margiotta-Casaluci et al. (2014). The observa-
tion tankwas divided visually into 3 areas of equal size (bottom,middle,
top), and the following endpoints quantified: number of entries into the
middle and top areas; percentage of time spent in each area; swimming
speed in each area. Fig. 1B illustrates our experimental approach
to assessing fish behaviour (top), as well as typical behaviour
tracks (bottom) of inactive and active control fish and positive control
(fluoxetine-exposed) fish.
2.3. Interpretation of results by experts
Experts in ecotoxicology were asked to interpret the behavioural re-
sults. We sought the opinions of all participants of the 18th UK-Japan
annual scientific workshop on research into environmental endocrine
disrupting chemicals. This workshop was held in Weymouth, UK on
24th – 25th October 2016. It was attended by 41 scientists, many of
whom could be considered experts in ecotoxicology. The UK provided
22 participants, Japan 17 and France 2. Approximately 40% of the partic-
ipantswere research scientists based in universities, 40%were scientists
working in government-funded organisations, including regulatory
bodies (e.g., Japan's Ministry of the Environment; UK's Environment
Agency) and the remaining 20% came either from industry or non-
governmental organisations. One of the authors of this paper (J.P.S.)
gave a talk at theworkshop entitled ‘The possible effects of the analgesic
tramadol on the behaviour of fish’. The talk consisted of one slide
outlining the experiment conducted (this is reproduced here as Fig. 1)
and two slides of the results (faithfully reproduced here as Figs. 2
and 3). During his talk the presenter did not provide any indication of
his personal opinions on the interpretation of the results. At the end of
the short talk the participants were each given a simple questionnaire
to complete. It consisted of 5 straightforward questions (see Fig. 4 for
those questions). The participants were instructed not to confer
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Fig. 1. Design of the experiment. Fish were exposed to various concentrations of tramadol (1, 10 and 100 μg/L) or a single concentration (100 μg/L) of the positive control fluoxetine (A).
Their behaviour was assessed both before and after exposure to those drugs in the novel tank diving test (B), which investigates anti-anxiety behavioural endpoints. Observational tanks
were divided into 3 areas (top, middle, bottom), fish behaviour videoed for 18min, and VideoTrack software then used to quantify the exploratory behaviour of the fish. Behaviour varied
substantially between individual fish, evenwithin the same treatment group; typical behaviours of inactive and active control fish are represented at the bottom of B, as is the behaviour of
a typical fish exposed to the positive control fluoxetine. Green indicates slow swimming and red fast swimming.
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tion of the data, the participants were asked not to identify themselves
on the forms. Hence, it is not possible to link any particular opinion to
any individual or job (i.e. research scientist, regulator). The key slides
displaying the data (Figs. 2 and 3 here) were on continuous display
while participants were completing their questionnaires. The scientists
had about 30 min to think about the results in front of them and com-
plete the questionnaire. During that time two questions were asked of
the presenter, both of which were about the number of fish in each
treatment group. In response the presenter reiterated the number that
he had stated earlier. Thirty-seven participants in the audience at the
time, none of whom are authors of this paper, returned their question-
naires, having answered all 5 questions.
2.4. Statistical analyses
All statistical analyses were conducted using the open source
statistical software R 3.5.1 GUI 1.70 for OS X 10.11 (El Capitan) and
higher (http://www.r-project.org). As it was not possible to link
pre-exposure data with post-exposure data for individual fish, non-
parametric Wilcoxon rank sum tests were conducted to compare the
behavioural data between pre-exposure and post-exposure periods.Treatment-related differences in all behavioural endpoints were
analysed by the non-parametric Kruskal−Wallis test followed by
Steel-Dwass post-hoc test (all-pairs multiple comparisons) and Steel
post-hoc test (comparisonswith SC). A p-value of b0.05was considered
statistically significant. A more in-depth analysis using logistic regres-
sion was also performed. Each behavioural parameter was dichoto-
mized by its median into 2 even groups, and the probability of the
behavioural occurrence was estimated in relation to the SC. Odds ratios
were estimated by generalized linear model or Bayesian generalized
linear model using the rstanarm package (Gabry, 2018). In addition,
odds ratios were estimated by generalized linear mixed model or
Bayesian generalized linear mixed model when including different
tanks as factor variables with random effects (on the intercept) on
binary data, by using glmmML (Broström, 2018) or rstanarm pack-
age, respectively, in statistical software R. In the Bayesian linear
modelling, we ran four chains with each sample size of 2000. For
each run, the first 1000 iterations were discarded for burn-in, and
the next 1000 iterations were used for the estimation. The convergence
was checked by ensuring R-hatwas below1.1 (Gelman et al., 2014). The
reported empirical 95% credible intervals represent the 2.5th to 97.5th
percentiles of the highest posterior density interval calculated from
the posterior samples.
Fig. 2. The behaviour of male fathead minnows in a novel tank diving test following their exposure to either 100 μg/L of tramadol or the positive control drug fluoxetine for 23–24 days.
Behaviour were recorded for 18 min after the fish were placed in the novel tank. After omitting the first 2 min and the last 1 min of data, the remaining 15 min of behavioural data was
analysed. n denotes the number of fish assessed. The time that fish spent in the Top+Middle area (left), swimming speed in the Top+Middle area (middle), and swimming speed in the
Whole area (right) are shown. The box-and-whisker plots show 25th percentile – 1.5 × IQR (lower whisker), 25th percentile (bottom edge of the box), 75th percentile (top edge of the
box), and 75th percentile +1.5 × IQR (upper whisker). The horizontal line in each box is the median value. The small dots (open circles) are outliers. Asterisks denote statistically
significant differences compared with the control (**p b 0.01; ***p b 0.001) based on the non-parametric Kruskal-Wallis test followed by Steel post-hoc test).
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3.1. Tramadol and fluoxetine concentrations in test water
Tramadol water concentrations (mean ± SD, n = 18) measured for
TG-1, TG-10, and TG-100 treatments were 1.1 ± 0.053, 9.9 ± 0.65, and
98 ± 5.2 μg/L, respectively (Tanoue et al., 2017). Fluoxetine water con-
centration (mean ± SD, n = 18) measured for the FG-100 treatment
was 94 ± 8.5 μg/L (Tanoue et al., 2017). Inter-tank variations were
within ±20%.
3.2. Tramadol and fluoxetine concentrations in fish plasma
Tramadol fish plasma concentrations (mean ± SD, n = 16)
measured after the exposure for TG-1, TG-10, and TG-100 treatments
were 1.0 ± 0.32, 5.9 ± 2.9, and 46 ± 12 ng/mL, respectively (Tanoue
et al., 2017). Plasma tramadol concentrations in fish following
exposure to the highest water concentration of tramadol (TG-100)
were slightly below the human therapeutic plasma concentration range
(100–300 ng/mL). Fluoxetine fish plasma concentrations (mean ± SD,
n = 16) measured after the exposure for FG-100 treatment were
6400 ± 1300 ng/mL (Tanoue et al., 2017), which is significantly
higher than the human therapeutic plasma concentration range
(120–500 ng/mL).
3.3. Behavioural assay
Behaviour was recorded for 18 min after the fish were placed in the
novel tank. After omitting the first 2 min and the last 1 min of data, the
remaining 15 min of behavioural data were analysed. The results of
three behavioural endpoints, namely the time that fish spent in the
Top + Middle area, swimming speed in the Top + Middle area, and
swimming speed in the Whole area, are summarized in Fig. 2. All fish
pre-exposure records as well as fish records from WC and SC groups
at post-exposure were combined and shown as control (baseline),
because there was no statistically significant difference between the
three groups. Most of the control fish spent almost all of their time at
the bottom of the tank and did not explore their new environment dur-
ing the recording period (see ‘Inactive control fish’ in Fig. 1B). Whereas
tramadol had no significant effect on where in the tank the fish spenttheir time, fish exposed to fluoxetine spent significantly more time
(p=0.0030) than either of the other two groups of fish in themiddle
and top areas of the tank; that is, they explored their novel tank more.
However, there was a large amount of variation in the behaviour of
fish in all groups (Fig. 2) – with some fish being relatively inactive
whereas others explored their novel tank very actively.
Fish exposed to fluoxetine swam more slowly in the Top + Middle
areas of their novel tank (p = 0.000018) than control fish (Fig. 2). Al-
though the median swimming speed of tramadol-treated fish in the
Top + Middle area of their tank was lower than that of control fish,
the difference was not statistically significant (p = 0.062). When me-
dian values of swimming speeds in the entire tank (whole areas) were
compared between treatments, there was no difference between the
three groups of fish (Fig. 2). These results indicate that only when fish
were exploring their novel tank for the relatively small percentage of
their time that they did so, they swam at different speeds depending
on the treatment.
Fig. 3 provides a more comprehensive picture of the behavioural
results. Behaviour both before and after exposure to the drugs is
compared, data for all three concentrations of tramadol are shown,
and the data for the replicate tanks within each treatment are shown,
allowing visualisation of tank to tank variation. One of themost striking
results was the very considerable variation that occurred in the behav-
iour of fish within a group of 8 fish. This variation is most obvious
when the time spent in the Top+Middle area of the tank is considered;
for example, itwas extremely variable in tank 2 ofWC.Not only did time
spent in the Top + Middle section of the tank often vary considerably
within a group of 8 fish, it also often varied appreciably between the
replicate tanks within a treatment; for example, compare the results
of tank 5 with those of tank 6 in the TG-1 group (Fig. 3A). However,
despite this high degree of variability in the time spent in the Top +
Middle area of the novel tank, there was an obvious effect of fluoxetine.
This drug increased the time that fish spent in the upper two thirds of
the tank, when pre- and post-exposure behaviours were compared,
although in only one tank was this statistically significant (Fig. 3A). In
contrast there was no evidence that tramadol affected the time fish
spent in the upper two thirds of the tank.
Swimming speed in the Top+Middle area of the novel tankwas very
similar pre- and post-exposure in both control groups (WC and SC)











Tank 1 Tank 2 Tank 3 Tank 4 Tank 5 Tank 6 Tank 7 Tank 8 Tank 9 Tank 10 Tank 11 Tank 12 
*p = 0.024





Time spent in the Top + Middle area (%)
Swimming speed in the Top + Middle area (cm/s)
 Pre-exposure         Post-exposure
WC SC TG-1 TG-10 TG-100 FG-100
WC SC TG-1 TG-10 TG-100 FG-100
A 
B
Fig. 3. A comparison of the behaviour of male fatheadminnows in a novel tank diving test both before and after exposure to various concentrations of tramadol (1, 10, and 100 μg/L) and
the positive control fluoxetine (100 μg/L). Data for replicate tanks for each treatment are shown. The time that fish spent in the Top+Middle areas (A) and swimming speed in the Top+
Middle areas (B) are shown. For each replicate n = 8 fish. Bars represent median values, with whiskers representing the maximum values. Asterisks denote statistically significant
differences between pre- and post-exposure for each tank (*p b 0.05; **p b 0.01; non-parametric Wilcoxon rank sum tests).
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tramadol were less clear. In one of the replicate tanks of the highest
concentration (TG-100), swimming speed was reduced significantly, but
it was not in the other replicate. There was no effect of the intermediate
concentration (TG-10), but in one of the replicates of the lowest
concentration (TG-1), the swimming speed was significantly lower
post-exposure, whereas it was unchanged in the other replicate (Fig. 3B).
3.4. Interpretation of results by experts
The results of the questionnaire are provided in Fig. 4. What is most
obvious about the answers provided by the ‘experts’ is that there was
relatively little agreement between them, whatever the question
asked. A few participants replied ‘maybe’ to a question even though
there was no box on the questionnaire for this equivocal answer
(the questionnaire was designed to force the participants to answer
‘yes’ or ‘no’). By answering ‘maybe’ the participants demonstrated
how difficult they found it to reach a firm conclusion. A quarter of the
participants thought that the highest concentration of tramadol had
an effect (Fig. 4, Question 1), despite only one of the replicates showing
a statistically significant effect, and for one endpoint only, namelyswimming speed (Fig. 3). Five out of the 37 respondents (14%) consid-
ered that the lowest concentration of tramadol also had an effect.
Interestingly, one of these 5 ‘experts’ did not think that the highest
concentration did, although the other 4 did. Themost disparate opinion
occurred when the participants were asked if they thought that low
concentrations of chemicals can cause effects that are not observed
when higher concentrations are tested. The participants were split
nearly 50:50 in response to this question (Fig. 4, Question 3). They
were split exactly equally when asked if they thought that a higher
concentration of tramadol (1000 μg/L)would have produced significant
effects on the behaviour of thefish, although 40% of the respondents an-
swered by saying ‘maybe’, meaning that they could not decide one way
or the other. The last question of the questionnaire asked participants
for any of their thoughts on how to interpret the data. Many of their
thoughts have been combined in Table 1. Their major thoughts were:
“More information on what normal behaviour is would be helpful.”
“The high degree of variability compromises interpretation of
the data.”
“The experiment needed to be larger and a more comprehensive
analysis of behaviour conducted.”
“Were appropriate statistics conducted?”
Do you think that the highest concentration of tramadol had an effect?
Do you think that the lowest concentration had an effect?
Do you think that the effects of some chemicals can be non-monotonic?
By this I mean that low concentrations produce effects that higher
concentrations do not.
If a higher concentration had been tested (e.g. 1000µg/L), do you think it
would have had an effect?
Do you have any other thoughts on how to interpret the data?



























Fig. 4. A summary of the independent opinions of 37 UK and Japanese ecotoxicologists based on the data shown in Figs. 2 and 3. Although the questionnaire provided only two options,
either ‘yes’ or ‘no’ to each question, some respondents nonetheless replied ‘maybe’.
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a more comprehensive statistical analysis of the behavioural data was
undertaken,mainly to determine if thatwould providemore convincing
answers as to whether or not tramadol affected the behaviour of the
fish. In addition to examining the data on swimming speed and the
proportion of their time the fish spent in the top, middle, and bottom
areas of the novel tank, the number of entries fish made into the top
and middle areas was also included in the analysis. Further, based on
the suggestion of Melvin et al. (2017) that different lengths of observa-
tion time can impact on basic swimming parameters, we separated the
behavioural data into two periods (2–10 min and 10–18 min) and
analysed each time period separately. There is logic in doing so because
fish might feel anxious when first placed in a novel tank, but after a
while become less anxious and explore their surroundings more. The
results of this more comprehensive analysis are presented in Fig. 5
and Table S1. Non-parametric Kruskal−Wallis test followed by Steel-
Dwass post-hoc test (all-pairs multiple comparisons) were conducted
on the behavioural data, as shown in Fig. 5, while non-parametric
Kruskal−Wallis test followed by Steel post-hoc test (comparisons
with SC) were also conducted, as shown in Table S1. The clearest result
is the effect of fluoxetine on the behaviour of the fish: fish treated with
this drug spentmore time in the upper two thirds of the novel tank and
swammore slowly in both thefirst (2–10min) and second (10–18min)
periods, as well as the entire observational period (2–18 min),comparedwith pre-exposure data (Fig. 5). Nevertheless, when compar-
ingwith the SC group, these differenceswere not statistically significant
(p=0.59 for time spent in the upper two thirds of the tank; p= 0.056
for swimming speed in the upper two thirds of the tank, Steel-Dwass
post-hoc test) (Fig. 5). Tramadol had no statistically significant effect
on any behavioural endpoints in both the first (2–10 min) and second
(10–18 min) periods. However, when data for the entire observational
period (2–18 min) were analysed, a statistically significant (p =
0.037, Steel-Dwass post-hoc test) lower swimming speed in the
Top + Middle area of the novel tank compared to the pre-exposure
data was detected for the highest concentration (TG-100), whereas
there was no statistically significant difference between the SC and
TG-100 groups (p = 1.0, Steel-Dwass post-hoc test) (Fig. 5). When
using the Steel post-hoc test (comparisons with SC), statistically
significant lower swimming speeds of fluoxetine-treated fish than SC
fish in the Top+Middle area of the novel tank was shown for all obser-
vation periods (Table S1). On the other hand, there was no statistically
significant difference between SC and tramadol-treated fish for any
behavioural endpoints (Table S1).
We further conducted logistic regression analyses for three behav-
ioural endpoints (number of entries to, percentage of time spent in,
and average swimming speed in, the Top + Middle area of the novel
tank) recorded during the full observation period (2–18 min). These
behavioural parameters were dichotomized by their medians into 2
Table 1
Representative comments by UK and Japanese experts on the difficulties associated with
interpreting the behavioural data collected during an experiment investigating the
possible effect of tramadol on fathead minnows.
A: Understanding normal behaviour
“One should pay attention to what is normal”
“Do we have background data on how fathead minnows would normally/typically
behave?”
“More baseline data are needed”
B: The degree of variability in behaviour
“I'm not sure any effect of tramadol can be discerned, given the variation of
controls (i.e. the difference between less-active and more-active control fish)”
“Were there enough replicates to understand the variability of behaviours?”
“Lack of consistency between tanks at same concentration – can't rule out tank effect”
“Control variability very high – not enough fish”
C: Issues with experimental design
“n is too small”
“The fluoxetine positive control showed similar responses in the replicate tanks.
This did not occur with the replicate tramadol tanks. I wonder if there are other
end-points one could examine, as this was only one? “
“Duplicate tanks is nowhere near enough for a study of this nature”
D: Issues with analysis of the results
“Are the statistical probabilities corrected for multiple testing?”
“If 20 statistical tests, one will be significant!”
“”I don't think this study can conclude if tramadol had effect or not. Individual
effects are probably small, so detecting effect is very difficult (underpowered)”
“Technically n = 2 with only two tanks, leading to pseudoreplication by treating
fish separately (include tank as random factor in statistical modelling)”
“Need to be sure statistical model is the correct one. Very different results seen
using very different statistics”
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estimated in relation to the SC group. The probabilities, which are
expressed as odds ratios, were estimated by generalized linear
(mixed)model or Bayesian generalized linear (mixed)model on the bi-
nary data. The results of these analyses are shown in Tables S2 and S3.
The logistic regression analyses revealed the association between
swimming speeds and treatments. Amongst all fish, those exposed to
fluoxetine were 8.3–9.6 times (depending on the generalized linear
model used) as likely to swim slowly in the upper two thirds of the
novel tank as the SC fish. For the other two behavioural parameters -
number of entries to the Top + Middle area and percentage of time
spent in the Top +Middle area of the novel tank - there was no associ-
ation with treatments.
The results obtained from these different statistical approaches to
examining any behavioural alteration are summarized in Fig. 6. All
statistical approaches detected the clear effect of fluoxetine on the
swimming speed (decreased swimming speed) in the upper two thirds
of the novel tank. Only a comparison between pre-exposure and post-
exposure data suggested that the lowest concentration of tramadol
(TG-1) and the highest concentration of tramadol (TG-100) had a
statistically significant effect on the swimming speed in the upper two
thirds of the novel tank. A statistically significant increase in the amount
of time fish spent in the upper two thirds of the novel tank was shown
for fluoxetine treatment, although only when comparing between pre-
exposure and post-exposure behavioural data.
4. Discussion
We conducted what we would consider a reasonably well-designed
study: in the experiment there was a relatively high number of fish in
each treatment (n = 16), two control treatments (water and solvent),
replicate tanks for each treatment, three concentrations of the psycho-
active drug tramadol, and a positive control group.We also assessed be-
haviour both before and after exposure to the drugs, using the widely
utilized novel tank diving test. In addition, the plasma and brain concen-
trations of the drugs in the fish were measured, thus demonstratinguptake of the drugs and their presence in the target organ, the brain
(see Tanoue et al., 2017). The highest water concentration of tramadol
(TG-100) produced fish plasma levels of tramadol (46 ± 12 ng/mL)
proximate to the human therapeutic plasma range of 100–300 ng/mL.
Yet despite this, an equivocal set of behavioural datawas obtained, lead-
ing to ‘experts’ having great difficulty in interpreting it. The inclusion of
the positive control drug, fluoxetine, confirmed that the experimental
design was robust. Fluoxetine increased the amount of time fish spent
exploring the novel tank and reduced their swimming speed in the
upper two thirds of the tank, as has been demonstrated before both
by us (Margiotta-Casaluci et al., 2014) and others (Cachet et al., 2010;
Ansai et al., 2016). Thus reproducible behavioural results can be ob-
tained. In contrast, the results with tramadol were unclear. There was
limited statistical support for both the highest and lowest concentra-
tions having modest effects on fish swimming speed in the upper two
thirds of the tank, but no evidence that the intermediate concentration
had any effect. A number of experts at the UK-Japan workshop sug-
gested in their comments (Table 1) that amore rigorous statistical anal-
ysis of the results was required, and that different statistical approaches
might lead to different conclusions being reached. We found a discrep-
ancy between statistical results when the highest concentration of
tramadol (TG-100) was compared with pre-exposure data or the SC
group. A statistically significant decrease in swimming speed in the
upper two thirds of the tank was found when the post-exposure data
of the TG-100 group was compared to the pre-exposure data of the
same group, whereas a statistically non-significant decrease in this pa-
rameter was found when the comparison was to the SC fish (Fig. 5
and Table S1). This discrepancymight be due to the slight difference be-
tween pre- and post-exposure values of the behavioural parameters in
the two control groups (WC and SC). Although therewas no statistically
significant difference between pre-exposure values and post-exposure
control (WC and SC) values, median values of swimming speed in the
upper two thirds of the tank in post-exposure WC and SC groups were
lower than that in pre-exposure group (Fig. 5). Nevertheless, when
comparing between pre-exposure and post-exposure data, the lowest
concentration of tramadol (TG-1) and the highest concentration of
tramadol (TG-100) showed statistically significant differences in the
swimming speed in the upper two thirds of the tank, while control
(WC and SC) fish did not show statistically significant differences in
the behavioural parameter between pre-exposure and post-exposure
(Fig. 5). The number of fish per treatment and the number of tanks
per treatment might not be enough to obtain statistically robust and re-
liable results, despite the experiment being a relatively large one involv-
ing nearly 100 fish.
The expert participants of the UK-Japan workshop obviously
reached different conclusions based on the same data. They did not
agree whether or not tramadol had affected the behaviour of the fish,
and were evenly split when asked if they thought a higher concentra-
tion of tramadol than any tested would have had an effect. Perhaps
most surprisingly, almost half of the respondents believe that low con-
centrations of a chemical can produce effects that higher concentrations
do not, although a similar number did not believe this was possible. We
accept that we did not use a very sophisticated approach to obtaining
the opinions of other scientists on the data they were shown. This was
not our intention. We wanted to obtain the immediate opinions of a
group of ‘experts’, and hence took the opportunity of the meeting of
Japanese and UK scientists held inWeymouth, UK, to obtain those opin-
ions.We are not aware of any other examples in the literature of similar
surveys. Thus, although our survey was relatively small (37 respon-
dents), and definitely should be considered preliminary, it appears to
be the only one conducted to date. The closest the existing literature
comes to attempting to do what we did is probably the paper by Kase
et al. (2016), who asked a group of chemical risk assessors to judge
the reliability and relevance of a small number of published ecotoxicity
studies. Their risk assessors also provided very varied opinions, despite
them being constrained (unlike those we surveyed) by having to make
Fig. 5. The behaviour of male fathead minnows in a novel tank diving test following their exposure to either various concentrations of tramadol or the positive control drug fluoxetine.
Behaviour was recorded for 18 min after the fish were placed in the novel tank. After omitting the first 2 min of data, when the fish were adjusting to their new surroundings, the
remaining 16 min of behavioural data were divided equally into 2–10 and 10–18 min periods to allow comparison between these two periods. The pre-exposure group (baseline)
consists of data from all fish records (n = 96) at pre-exposure period, whereas all subsequent treatment groups consist of data from 16 fish for each treatment. The box-and-whisker
plots show 25th percentile – 1.5 × IQR (lower whisker), 25th percentile (bottom edge of the box), 75th percentile (top edge of the box), and 75th percentile +1.5 × IQR (upper
whisker). The horizontal line in each box is the median value. The small dots (open circles) are outliers. Statistically significant differences (p b 0.05, non-parametric Kruskal-Wallis
test followed by Steel-Dwass post-hoc test) between treatments are marked by different alphabetical letters.
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Fig. 6. A summary of the results obtained from using different statistical approaches to analyse the behavioural data. Grey, red, and blue represent no significant effect, a significant
increase, and a significant decrease, respectively.
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not allowed – and did not take place – in order that we obtained inde-
pendent opinions. We are not suggesting that experienced regulators,
if presented with all the literature on the effects of psychoactive drugs
on fish, and given as much time as they wanted, would reach the
same conclusions that the group of scientists we asked reached. But
again this was not the point of our approach. Irrespective of any per-
ceivedweaknesses of our approach, the results very clearly demonstrate
that experienced scientists can reach very different conclusions when
presented with a set of equivocal data, probably as a consequence of
thempossessing different knowledge, having had different experiences,
and possibly even possessing different prejudices. In other words, their
opinions on the interpretation of the data were influenced by confirma-
tion bias. Confirmation bias is a tendency to interpret and/or recall
information in a way that confirms one's pre-existing beliefs. Thus, for
example, if a scientist already believes that low concentrations of a
chemical can cause effects not produced by higher concentrations of
that same chemical, then when shown the data presented here in
Fig. 3, confirmation bias would lead them to conclude that the data
are an example of a ‘low dose’ effect, leading to a non-monotonic
dose-response relationship. Those scientists who do not believe in
‘low dose’ effects will conclude from the same data that the apparent
effect of the lowest concentration tested is probably an artefact due to
chance, and hence likely would not be reproducible. Both groups of
scientists would be succumbing to confirmation bias if they let their
pre-existing opinions unduly influence their interpretation of the data
shown to them in this study. Formal training of risk assessors and
research scientists, which is largely lacking presently, would probably
improve their judgement of experimental results.
One feature of the results that stands out is the very variable nature
of the response of a fish to a novel environment. This high degree of in-
dividual variability in behaviour, of both control and drug-treated fish,
has been noted by others (e.g., Margiotta-Casaluci et al., 2014; Huerta
et al., 2016). One way to deal with this high degree of variability in
laboratory toxicity tests would be to substantially increase the number
of fish (or other animals) used in an experiment, thereby increasing
statistical power. This was suggested by some of the experts, whomade comments such as “n is too small” and “duplicate tanks is no-
where near enough for a study of this nature”. However, our experiment
involved the use of 96 fish (16 fish per treatment), which is more than
many authors have used in their studies investigating the possible
effects of various psychoactive drugs on the behaviour of fish
(e.g., Bisesi Jr. et al., 2016 used 5 fish per treatment; Kohlert et al.,
2012 used 48 fish in total; Valenti Jr. et al., 2012 used 60 fish in total;
Brodin et al., 2017 used 37 fish in total). Using a higher number of fish
would also create ethical problems, as society tries to cease using live
animals in research. A better strategy would be to improve the under-
standing of fish behaviour. Why, for example, when placed into a
novel tank, do some fish dive to the bottom and ‘freeze’ there, whereas
others explore their new tank? How repeatable are these behaviours?
As a first step it would be very useful to analyse the behaviour of control
fish, to determine what is normal and the degree of variation. Thus, we
are strongly in support of the comments made by a number of our ex-
perts, such as “one should pay attention to what is normal” and “do
we have background data on how fathead minnows would normally/
typically behave?” The answer to that final question, not only for the
fathead minnow but for all species of fish, is undoubtedly ‘no’.
Two important issues arise from this study: one from the experi-
mental component and one from the social science component. The
experimental component demonstrates that not enough is known
presently about how and why fish behave as they do to enable robust
conclusions to be reached on how chemicalsmight affect that behaviour
and the consequences of any changes in behaviour induced by
chemicals. Far too often normal behaviour is not established; that is,
the baseline is unknown (Harris et al., 2014). Very helpfully, recent
studies have begun to address both the variation in behaviour between
individual fishwithin a species as well as the repeatability of the behav-
iour of each fish (e.g., Thoré et al., 2018). Collaboration between
ecotoxicologists and behavioural ecologists, which is currently very
rare, would be extremely advantageous in this regard.
The social science component (the survey) very clearly shows that
different scientists, whether they are researchers or regulators, can
reach entirely different conclusions from the same set of data. This is,
of course, more likely to be the case when the data are equivocal, as
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choactive drugs might affect the behaviour of fish, but instead is likely
to be true for any effect and any chemical. Currently formal training in
behavioural toxicology and in the design and interpretation of animal
behavioural studies is not common within the ecotoxicology commu-
nity. Given the lack of formal training in this aspect of biology, perhaps
it is not surprising that ‘our’ group of experts reached the very varied
opinions that they did. Considering the recent growing concern about
the alteration of wildlife behaviour potentially induced by chemicals
in the environment, that situation suggests that formal training in
behavioural biology would be advantageous to both ecotoxicology re-
searchers and regulators. Such training should lead to a more appropri-
ate interpretation of behavioural toxicology data and their potential
ecological implications, and consequently be used to better protect the
environment from chemicals.
5. Conclusions
The presence of psychoactive drugs in the aquatic environment
should be taken seriously, and it is important to understand whether
or not their presence constitutes a significant risk to aquatic organisms.
Yet despite more than a decade of academic research, we still do not
know. In this study, an experiment was conducted in which fish were
exposed to the synthetic opiate tramadol for over 3 weeks, then their
anxiolytic behaviour assessed in a novel tank diving test. It produced
equivocal results that are difficult to interpret. There was weak but sta-
tistically significant support for an effect of the highest concentration
tested, and also at the lowest. The intermediate concentration had no
apparent effect. Thus there was no clear concentration-response re-
lationship. When a large group of independent experts, comprising
both research scientists and regulators, was asked for its opinion
on the results, these were highly variable; some experts concluded
that tramadol had affected the behaviour of the fish, whereas others
did not. Half of these experts believe that low concentrations of a
chemical can cause effects that higher concentrations do not. Given
the very inconsistent literature on the effects of psychoactive drugs
on aquatic organisms, and the equally variable thinking and opinions
of ecotoxicology experts, it appears impossible presently to conduct
a meaningful aquatic risk assessment for any psychoactive drug.
This situation is unlikely to change until considerably more is
known about the normal behaviour of fish and the degree of individ-
ual variability. Given the very considerable difficulties associated
with understanding the effects of psychoactive drugs in humans
(e.g., Cipriani et al., 2018 for anti-depressants), even after millions of
people have been treated with these drugs for decades, it is perhaps
not surprising that difficulties are being encountered in determining
whether or not they affect the behaviour of aquatic organisms, and if
so, at what concentrations.
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